An observational study in Corneal Disease, sponsored by Benha University. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-05-29.
Sponsored by Benha University · Observational
Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced vision, photophobia, glare, halos, and foreign body sensation.
first group of patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.S econd group underwent transepithelial PTK for subepithelial infiltrates. Baseline and post-treatment full ophthalmic examination was done.
130 studies on the registry are indexed under Corneal Diseases; 43 are open to participants now.
This study's enrollment of 63 is below the median of 102 across 46 observational studies indexed under Corneal Diseases.
Browse Corneal Diseases studies →Benha University is the lead sponsor of 356 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
60 patients with adenoviral SEI
Exclusion Criteria:
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
Drug: Tacrolimus ointment
Patients underwent transepithelial PTK for subepithelial infiltrates.
Procedure: phototherapeutic keratectomy
patients received only artificial tears eyedrop
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
Also known as: Protopic ointment
Patients underwent transepithelial PTK for subepithelial infiltrates.
changes of corneal densitometry
Sub epithelial infiltrates was examined with the densitometry programme of the Pentacam (Fa. Oculus,Weimar, Germany)
Time frame: 6 months
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Benha University